AIA Group Ltd Purchases Shares of 5,600 Humana Inc. (NYSE:HUM)

Key Points

• AIA Group Ltd has acquired 5,600 shares of Humana Inc. valued at approximately $1.48 million, marking a significant investment in the insurance sector.
• Institutional investors and hedge funds collectively own 92.38% of Humana's stock, indicating strong institutional interest in the company.
• Humana's shares showed a yearly performance fluctuation, reaching a 12-month low of $206.87 and a high of $382.72, highlighting variability in market value.

AIA Group Ltd acquired a new position in shares of Humana Inc. (NYSE:HUM - Free Report) during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 5,600 shares of the insurance provider's stock, valued at approximately $1,482,000.

A number of other institutional investors have also recently added to or reduced their stakes in HUM. Vanguard Group Inc. raised its position in Humana by 8.9% in the first quarter. Vanguard Group Inc. now owns 13,972,872 shares of the insurance provider's stock valued at $3,697,222,000 after purchasing an additional 1,143,662 shares during the period. Dodge & Cox lifted its position in Humana by 106.7% during the 4th quarter. Dodge & Cox now owns 10,198,040 shares of the insurance provider's stock worth $2,587,345,000 after acquiring an additional 5,264,045 shares during the period. Pzena Investment Management LLC raised its stake in shares of Humana by 6.1% during the 1st quarter. Pzena Investment Management LLC now owns 3,828,923 shares of the insurance provider's stock worth $1,013,133,000 after buying an additional 219,541 shares in the last quarter. Davis Selected Advisers increased its stake in Humana by 3.3% in the 1st quarter. Davis Selected Advisers now owns 2,331,343 shares of the insurance provider's stock valued at $616,873,000 after purchasing an additional 74,434 shares in the last quarter. Finally, T. Rowe Price Investment Management Inc. grew its holdings in Humana by 11.1% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 1,605,771 shares of the insurance provider's stock valued at $407,401,000 after buying an additional 160,952 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company's stock.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on HUM. Wells Fargo & Company reduced their price objective on Humana from $348.00 to $344.00 and set an "overweight" rating on the stock in a research note on Thursday. Truist Financial cut their price objective on Humana from $280.00 to $260.00 and set a "hold" rating for the company in a report on Wednesday, July 16th. Bank of America dropped their price objective on Humana from $320.00 to $260.00 and set a "neutral" rating on the stock in a research note on Tuesday, June 17th. Cantor Fitzgerald reaffirmed a "neutral" rating and set a $290.00 price objective on shares of Humana in a report on Thursday, May 1st. Finally, Morgan Stanley reduced their target price on Humana from $290.00 to $277.00 and set an "equal weight" rating on the stock in a report on Thursday, July 31st. Eighteen analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $281.45.

Humana Stock Performance

Shares of NYSE HUM traded up $5.39 during midday trading on Friday, reaching $286.73. The company's stock had a trading volume of 1,729,806 shares, compared to its average volume of 1,734,631. Humana Inc. has a 12-month low of $206.87 and a 12-month high of $382.72. The firm has a 50 day moving average price of $241.58 and a 200-day moving average price of $253.94. The stock has a market capitalization of $34.49 billion, a P/E ratio of 22.01, a PEG ratio of 1.66 and a beta of 0.44. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.95 and a quick ratio of 1.95.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $6.27 EPS for the quarter, missing the consensus estimate of $6.32 by ($0.05). The firm had revenue of $32.39 billion during the quarter, compared to analysts' expectations of $31.85 billion. Humana had a net margin of 1.28% and a return on equity of 13.67%. Humana's revenue for the quarter was up 9.6% on a year-over-year basis. During the same quarter in the previous year, the company posted $6.96 EPS. As a group, equities analysts predict that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.